Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac and extracardiac outcomes after heart transplantation in laminopathies.

Heart (British Cardiac Society)·2026
Same author

Quadricuspid aortic valve repair: Tricuspidization with a double-ring annuloplasty.

JTCVS techniques·2026
Same author

Authors' Perspective-Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Full percutaneous decannulation of VA-ECMO using MANTA<sup>®</sup> and Femoseal<sup>®</sup> devices: a propensity-score based study.

Critical care (London, England)·2026
Same author

Ventricular arrhythmia ablation timing and outcomes in electrical STORM requiring V-A ECMO support: the STORM-ECMO study.

Critical care (London, England)·2026
Same author

Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year Update.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

2.4K

[Cardiac graft allocation].

Pascal Leprince

    Bulletin De L'Academie Nationale De Medecine
    |August 29, 2014
    PubMed
    Summary
    This summary is machine-generated.

    French cardiac graft allocation prioritizes local teams and national lists for critical patients. While HE1 patients show poorer survival, their transplantation offers greater survival benefits, necessitating careful graft acceptance and multidisciplinary decisions for fairness.

    More Related Videos

    Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
    08:49

    Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

    Published on: August 2, 2024

    1.4K
    An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
    09:25

    An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

    Published on: May 8, 2020

    7.2K

    Related Experiment Videos

    Last Updated: Apr 25, 2026

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
    08:44

    Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

    Published on: June 23, 2022

    2.4K
    Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
    08:49

    Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

    Published on: August 2, 2024

    1.4K
    An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
    09:25

    An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats

    Published on: May 8, 2020

    7.2K

    Area of Science:

    • Cardiology
    • Transplantation Medicine
    • Public Health Policy

    Context:

    • French cardiac graft allocation evolved from center-based to include national priority lists (HE1 and HE2) in 2004.
    • HE1 designates patients with unstable hemodynamics (inotropes, ECMO), while HE2 is for those with complications during long-term circulatory support.
    • Initial data suggest poorer survival for HE1 patients compared to HE2 patients.

    Purpose:

    • To analyze the French cardiac graft allocation system, evaluating the impact of national priority lists (HE1, HE2) on patient survival.
    • To examine the complexities beyond allocation rules, including graft quality assessment and patient risk stratification for waiting list inclusion.
    • To underscore the need for a multidisciplinary approach in cardiac transplantation decision-making.

    Summary:

    • While HE1 patients exhibit lower survival rates, their potential survival benefit post-transplantation is significantly higher than HE2 patients.
    • Mortality during long-term circulatory support is a critical factor not fully captured in HE2 survival data.
    • Graft quality and individual patient risk assessment introduce heterogeneity, impacting waiting times and transplant outcomes.
    • The study highlights that medical decisions, independent of allocation rules, significantly influence transplant success and fairness.

    Impact:

    • The findings emphasize that current allocation rules do not fully account for the nuances of patient acuity and graft quality.
    • A multidisciplinary decision-making process is crucial for ensuring equitable and effective cardiac graft allocation.
    • This research informs policy and clinical practice to optimize cardiac transplantation outcomes and fairness across the national waiting list.